Home › NCT05517967
An Examination of Brown Adipose Tissue and Energy Expenditure in Infants
Who can join
5 Weeks · All sexes
Full eligibility criteria
Inclusion Criteria: * aged 0 weeks to less than 3 weeks at visit 1 * be willing to complete MRI procedures Exclusion Criteria: * Unable to complete two clinic visits within 14 days * Born with health conditions that would render the procedures unsafe * Born earlier than 36 and 0 days gestation * Taken a steroid drug since birth * Implanted metal or electronic objects that render MRI unsafe
About the study
Excess fetal adipose tissue growth during intrauterine development increases future obesity risk. Development of brown adipose tissue, a highly thermogenic organ in utero, may affect postnatal energy expenditure, thus influencing obesity risk. This pilot research study is designed to understand the developmental origins of energy balance by examining maternal and neonatal factors that influence neonatal brown adipose tissue and to quantify its physiological relevance to energy expenditure in human neonates.
Sponsor: Pennington Biomedical Research Center · Participants: 60 · Started: Aug 17, 2022
Contact the study team
- Emily W Flanagan, PhD · Phone: 225-763-2828
- Abby D Altazan, MS · Phone: 225-763-2801
Official record on ClinicalTrials.gov — NCT05517967
Locations in the U.S.
| Louisiana | Pennington Biomedical Research Center, Baton Rouge |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.